KLF6 expression is elevated in ovarian malignancies, KLF8 promotes cellular proliferation in HCC, gastric, and glioma carcinomas, while KLF3 and KLF14 have been reported to inhibit tumor growth in breast and brain tumors, respectively [42, 43, 81]. Here, KLF8 is linked to hepatocellular carcinoma.